Literature DB >> 10226536

Combined effect of alkyl-lysophospholipid and vincristine on proliferation, migration and invasion in human glioma cell lines in vitro.

H K Haugland1, S J Nygaard, O B Tysnes.   

Abstract

The aim of the present study was to investigate the combined effect of the alkyl-lysophospholipid Et-18-0-CH3 (ALP) and vincristine (VCR) on the proliferative, migratory and invasive properties of human glioma cells. Both drugs have previously been shown to act upon the locomotive apparatus of the cell. In the glioma cell lines D37MG and GaMG we found that ALP and VCR inhibited proliferation in monolayer growth as well as in multicellular spheroids in a dose-dependent manner. When combined, the two drugs had a significantly enhanced effect upon proliferation in the cell line GaMG but not in D37MG. Migration was inhibited by ALP and VCR in a dose-dependent manner in both cell lines. An enhanced effect by combining the drugs was also observed. The invasion of glioma cells into the brain cell aggregates was markedly inhibited at lower concentrations than needed for the inhibition of proliferation and migration when ALP and VCR were applied alone, without any further enhancement by combining the drugs. It is concluded that the combination of ALP and VCR have additive anti-proliferative and anti-migratory properties in human glioma cell lines.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10226536

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

Review 1.  Biological mechanisms of glioma invasion and potential therapeutic targets.

Authors:  B B Tysnes; R Mahesparan
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

2.  The SK3/K(Ca)2.3 potassium channel is a new cellular target for edelfosine.

Authors:  M Potier; A Chantome; V Joulin; A Girault; S Roger; P Besson; M-L Jourdan; J-Y LeGuennec; P Bougnoux; C Vandier
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

3.  Effects of ionizing radiation in combination with Erufosine on T98G glioblastoma xenograft tumours: a study in NMRI nu/nu mice.

Authors:  Guido Henke; Verena Meier; Lars H Lindner; Hansjörg Eibl; Michael Bamberg; Claus Belka; Wilfried Budach; Verena Jendrossek
Journal:  Radiat Oncol       Date:  2012-10-18       Impact factor: 3.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.